BSE · PARMAX.BO
Parmax Pharma Limited
₹135.05-₹1.35 (-0.99%)
Parmax Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 2.91% below the high.
Loading market information…
BSE · EMMESSA.BO · INR
Stock price, earnings
Quote as of Oct 29, 2026, 09:42 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Emmessar Biotech & Nutrition Limited’s quoted price sits in the lower half of its reported 52-week range, 31.52% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Emmessar Biotech & Nutrition Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Emmessar Biotech & Nutrition Ltd. specializes in the creation and distribution of health-related and dietary products. The company's operations are segmented into Healthcare, Fine Chemicals, and income generated from leased property. Its product offerings encompass solutions for dermatological care, general wellness, musculoskeletal support, pain management, and sexual health. Established by Mathurakavi Srinivas Raghavan Ayyangar on March 17, 1992, the firm is headquartered in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹135.05-₹1.35 (-0.99%)
Parmax Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 2.91% below the high.
₹43.00+₹5.00 (+13.16%)
Novateor Research Laboratories’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
₹130.85₹0.00 (0.0%)
Chemo Pharma Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 13.91% below the high.
₹72.39+₹2.39 (+3.41%)
Colinz Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 17.65% below the high.
₹20.39-₹0.01 (-0.05%)
Vanta Bioscience Limited’s quoted price sits in the lower half of its reported 52-week range, 29.69% below the high.
₹14.05-₹0.57 (-3.9%)
Norris Medicines Limited’s quoted price sits in the lower half of its reported 52-week range, 29.96% below the high.
₹5.01₹0.00 (0.0%)
Cian Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 34.6% below the high.
₹26.90₹0.00 (0.0%)
Desh Rakshak Aushdhalaya Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.34% below the high.
